You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
Phar ma ceu ti cal Sales: US$ 95-100 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 55-60%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 75-80%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
VOVERAN (antirheumatic non-steroidal;<br />
antirheumatic top i cal; oph thal mic anti-in flam ma -<br />
tory non-steroidal)<br />
METHERGIN (la bor in ducer)<br />
TEGRITAL (antiepileptic)<br />
OTRIVIN (na sal prep a ra tion top i cal)<br />
CAL CIUM SANDOZ (cal cium prod uct)<br />
Ther a peu tic Range:<br />
anti rheu ma tics sys temic 31%<br />
min eral sup ple ments 17%<br />
gynecologicals other 11%<br />
na sal prep a ra tions 10%<br />
antiepileptics 10%<br />
Lead ing Dose Forms:<br />
coated tab lets 34%<br />
tab lets 20%<br />
liq uids 18%<br />
am poules 18%<br />
gels/sols 5%<br />
SANDOZ<br />
Full Name: Sandoz Pri vate Ltd<br />
Street Ad dress: Plot Nos. D-31 & D-32, MIDC<br />
TTC In dus trial Area Turbhe, Turbhe, Navi Mumbai<br />
400705<br />
Tel: +91 22 55910485<br />
Fax: +91 22 55910472<br />
Home Page: www.novartis.co.in<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 20-22 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 55-60%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 85-90%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
REGESTRONE (pro ges to gen)<br />
PZA CIBA (antitubercular prod uct)<br />
RIMACTAZID (antitubercular prod uct)<br />
FORISTAL (an ti his ta mine sys temic)<br />
CURAM (pen i cil lin broad spec trum)<br />
Ther a peu tic Range:<br />
sex hor mones sys temic 29%<br />
antibacterials sys temic 25%<br />
antimycobacterials 24%<br />
an ti his ta mines sys temic 6%<br />
antihypertensives 4%<br />
Lead ing Dose Forms:<br />
tab lets 56%<br />
coated tab lets 24%<br />
vi als 10%<br />
liq uids 7%<br />
cap sules 3%<br />
INDONESIA<br />
CIBA VI SION<br />
Full Name: PT. CIBA Vi sion Batam<br />
Street Ad dress: Jalan Beringin Kav. 204,<br />
Batamindo In dus trial Park, Mukakuning, Batam<br />
29433<br />
Tel: +62 77 0611048<br />
Fax: +62 77 0611035<br />
Home Page: www.id.novartis.com<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
HEXAL<br />
Full Name: PT Prima Hexal<br />
Street Ad dress: Wisma BSG, 5th floor, Jl.Ab dul<br />
Muis No.40, Ja karta-Pusat 10160<br />
Tel: +62 21 34834333<br />
Fax: +62 21 34834334<br />
Email: prod uct@primas-hexal.co.id<br />
Home Page: www.prima-hexal.co.id<br />
De scrip tion: De vel oper, man u fac turer, for mu la -<br />
tor, packager/as sem bler, im porter, ex porter, pro -<br />
moter, sales/detailer. Man u fac tures, ex ports for<br />
other com pa nies. Prod uct ranges in clude: phar -<br />
ma ceu ti cal prod ucts (branded, unbranded, pre -<br />
scrip tion, non-pre scrip tion), hos pi tal<br />
pharmaceuticals, di ag nos tic prod ucts, di -<br />
etetic/nu tri tional prod ucts, herbal prod ucts. Es -<br />
tab lished 1999. 526 pharmaceutical employees in<br />
2005.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 281 (2005)<br />
Con tacts (Pharm): Chair man: Holger Guenzel;<br />
Com mer cial Op er a tions: Rohyat Indrawijaya;<br />
Man u fac ture: Jenny Timotiwu; Re search & De vel -<br />
op ment: Jin Nurhayati; Gen eral Con tact: Holger<br />
Guenzel<br />
Sub sid iary of: Sandoz, Ger many (94%) (group:<br />
Novartis, Swit zer land); Salutas, Ger many (6%)<br />
(group: Novartis, Swit zer land)<br />
NOVARTIS<br />
Full Name: PT. Novartis In do ne sia<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 177